| Sep 19 |
Implied Volatility Surging for Sarepta Therapeutics (SRPT) Stock Options
|
| Sep 19 |
Sarepta Therapeutics Muscles Up In DMD Race
|
| Sep 16 |
Sarepta Therapeutics Appoints Deirdre Connelly to its Board of Directors
|
| Sep 14 |
Sarepta Therapeutics, Inc. (SRPT): Among Hedge Funds’ Top Biotech Stock Picks
|
| Sep 13 |
These 2 Biotech Stocks Are Set to Soar
|
| Sep 8 |
Sarepta Therapeutics, Inc. (SRPT): This Biotech Stock Should Be On Your Radar
|
| Sep 6 |
Why Is Sarepta Therapeutics (SRPT) Down 1.9% Since Last Earnings Report?
|
| Sep 5 |
Sarepta Therapeutics Announces Recipients of the 7th Annual Route 79, The Duchenne Scholarship Program, for the 2024-2025 Academic Year
|
| Sep 3 |
Muscle Disease Drug Developer Dyne Therapeutics Stock Plunges After Updated Data From Duchenne Muscular Dystrophy
|
| Aug 30 |
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
